• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Carlyle Secured Lending, Inc. Prices Public Company Offering of $300 Million 5.750% Unsecured Notes Due 2031

    9/30/25 5:01:04 PM ET
    $CG
    $CGBD
    Investment Managers
    Finance
    Finance: Consumer Services
    Finance
    Get the next $CG alert in real time by email

    NEW YORK, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Carlyle Secured Lending, Inc. (NASDAQ:CGBD) (the "Company") today announced that it has priced an underwritten public offering of $300 million in aggregate principal amount of 5.750% unsecured notes due 2031 (the "Notes"). The Notes will mature on February 15, 2031 and may be redeemed in whole or in part at the Company's option at the applicable redemption price. The offering is expected to close on October 7, 2025, subject to customary closing conditions.

    The Company intends to use the net proceeds from this offering to repay outstanding debt including the Company's revolving credit facility (which the Company intends to use to repay its subsidiary's revolving credit facility), to fund new investment opportunities, and for other general corporate purposes, which may include opportunistic repurchases of outstanding debt.

    J.P. Morgan Securities LLC, Barclays Capital Inc., BofA Securities, Inc., Citigroup Global Markets Inc., Deutsche Bank Securities Inc., Morgan Stanley & Co. LLC, Goldman Sachs & Co. LLC, HSBC Securities (USA) Inc., and R. Seelaus & Co., LLC are acting as joint book-running managers for this offering. ICBC Standard Bank Plc, B. Riley Securities, Inc., Citizens JMP Securities, LLC, Keefe, Bruyette & Woods, Inc., Lucid Capital Markets, LLC, Oppenheimer & Co. Inc., and Raymond James & Associates, Inc. are acting as co-managers for this offering.

    Investors are advised to carefully consider the investment objectives, risks and charges and expenses of the Company before investing. The pricing term sheet dated September 30, 2025, preliminary prospectus supplement, dated September 30, 2025, and the accompanying prospectus, dated April 29, 2024, each of which has been filed with the U.S. Securities and Exchange Commission (the "SEC"), contain a description of these matters and other information about the Company and should be read carefully before investing.

    The Company's shelf registration statement is on file with the SEC and is effective. The offering is being made solely by means of a preliminary prospectus supplement and an accompanying prospectus, which may be obtained for free by visiting the SEC's website at www.sec.gov or by contacting J.P. Morgan Securities LLC, 383 Madison Avenue, New York, New York 10179, Attn: Investment Grade Syndicate Desk, facsimile: 212-834-6081 or by calling at 1-212-834-4533; Barclays Capital Inc., 745 Seventh Avenue, New York, New York 10019, Attention: Syndicate Registration, facsimile: 646-834-8133 or by calling at 1-888-603-5847; BofA Securities, Inc.,NC1-022-02-25, 201 North Tryon Street, Charlotte, North Carolina 28255-0001, Attn: Prospectus Department, email: [email protected] or by calling toll-free at 1-800-294-1322; Citigroup Global Markets Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717, Telephone: (800) 831-9146, email: [email protected]; Deutsche Bank Securities Inc., 1 Columbus Circle, New York, New York 10019, Attention: Debt Capital Markets Syndicate, email: [email protected] or by calling at 1-800-503-4611; or Morgan Stanley & Co. LLC, 1585 Broadway, 29th Floor, New York, New York 10036, Attn: Investment Banking Division, facsimile: 203-719-0495 or by calling toll-free at 1-866-718-1649.

    The information in the pricing term sheet, the preliminary prospectus supplement, the accompanying prospectus and this press release is not complete and may change. The pricing term sheet, the preliminary prospectus supplement, the accompanying prospectus, and this press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of, the Notes in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or other jurisdiction.

    About Carlyle Secured Lending: Carlyle Secured Lending, Inc. is a closed-end, non-diversified and externally managed investment company that has elected to be regulated as a business development company under the Investment Company Act of 1940, as amended. Our objective is to generate current income and capital appreciation by sourcing and providing senior secured debt investments to U.S. companies in the middle market that are generally backed by private equity sponsors. The Company is managed by Carlyle Global Credit Investment Management L.L.C., an SEC-registered investment adviser and a wholly owned subsidiary of Carlyle. We derive significant benefit from our ability access and leverage Carlyle's significant scale, vast resources and world-class talent.

    About Carlyle: Carlyle (NASDAQ:CG) is a global investment firm with deep industry expertise that deploys private capital across three business segments: Global Private Equity, Global Credit and Carlyle AlpInvest. With $465 billion of assets under management as of June 30, 2025, Carlyle's purpose is to invest wisely and create value on behalf of its investors, portfolio companies and the communities in which we live and invest. Carlyle employs more than 2,300 people in 27 offices across four continents.

    Forward-Looking Statements

    Statements included herein contain certain "forward-looking statements" within the meaning of the federal securities laws, including statements with regard to the Company's Notes offering and the anticipated use of the net proceeds of the offering. You can identify these statements by the use of forward-looking terminology such as "anticipates," "believes," "expects," "intends," "will," "should," "may," "plans," "continue," "believes," "seeks," "estimates," "would," "could," "targets," "projects," "outlook," "potential," "predicts" and variations of these words and similar expressions to identify forward-looking statements, although not all forward-looking statements include these words. You should read statements that contain these words carefully because they discuss our plans, strategies, prospects and expectations concerning our business, operating results, financial condition and other similar matters. We believe that it is important to communicate our future expectations to our investors. There may be events in the future, however, that we are not able to predict accurately or control. You should not place undue reliance on these forward-looking statements, which speak only as of the date on which we make it. Factors or events that could cause our actual results to differ, possibly materially from our expectations, include, but are not limited to, the risks, uncertainties and other factors we identify in the sections entitled "Risk Factors," "Supplementary Risk Factors" and "Special Note Regarding Forward-Looking Statements" in filings we make with the SEC, and it is not possible for us to predict or identify all of them. We undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

    Contacts: 
      
    Investors: Media:
    Nishil MehtaKristen Ashton
    +1 (212) 813-4918+1 (212) 813-4763
    [email protected][email protected]



    SOURCE: 
    Carlyle Secured Lending, Inc.



    Primary Logo

    Get the next $CG alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CG
    $CGBD

    CompanyDatePrice TargetRatingAnalyst
    Carlyle Secured Lending Inc.
    $CGBD
    2/25/2026$13.00Neutral → Buy
    B. Riley Securities
    The Carlyle Group Inc.
    $CG
    2/24/2026$67.00Outperform
    RBC Capital Mkts
    The Carlyle Group Inc.
    $CG
    12/11/2025$74.00Buy
    UBS
    Carlyle Secured Lending Inc.
    $CGBD
    12/8/2025Mkt Perform
    Citizens JMP
    Carlyle Secured Lending Inc.
    $CGBD
    10/7/2025$15.00Mkt Perform → Outperform
    Raymond James
    The Carlyle Group Inc.
    $CG
    10/3/2025$74.00Outperform
    BMO Capital Markets
    Carlyle Secured Lending Inc.
    $CGBD
    10/1/2025$12.50Underweight → Neutral
    Analyst
    Carlyle Secured Lending Inc.
    $CGBD
    7/25/2025$15.00Equal Weight → Overweight
    Wells Fargo
    More analyst ratings

    $CG
    $CGBD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Acentra Health Names New Senior Vice Presidents, Mohamed Karama and Nirav Dalal, to Drive Company Growth and Business Development

    MCLEAN, Va., March 25, 2026 (GLOBE NEWSWIRE) -- Acentra Health, a technology and health solutions and services company dedicated to accelerating better outcomes for its government and commercial healthcare clients and the populations they serve, announced today that Mohamed Karama has joined the company as Senior Vice President of Growth Acceleration and Performance, and Nirav Dalal has been promoted to Senior Vice President of Sales Leadership. These appointments advance Acentra Health's transformation initiatives and position the company for strategic growth. "As we continue transforming Acentra Health, we're investing in our growth engine," said Patty Obermaier, EVP, Chief Growth Offic

    3/25/26 9:33:00 AM ET
    $CG
    Investment Managers
    Finance

    SpendHound Reaches 1,000 Customers in only Two Years, Welcomes ZoomInfo as Enterprise Momentum Continues

    Rapid growth signals strong enterprise adoption and market momentum SpendHound, a subsidiary of YipitData and the #1 rated SaaS spend management platform on G2 that gives finance teams total visibility into software spend, today announced it has reached 1,000 customers in only two years, marking a major milestone in the company's breakout growth. The achievement is highlighted by the addition of ZoomInfo (NASDAQ:GTM), the leading go-to-market intelligence platform, as the company's 1,000th customer. "Reaching 1,000 customers is a huge milestone for our team and a clear signal of the trust the market has placed in us," said Vinicius Vacanti, Co-founder and CEO of YipitData. "Welcoming

    3/23/26 9:00:00 AM ET
    $CG
    $GTM
    Investment Managers
    Finance
    Computer Software: Prepackaged Software
    Technology

    Resonetics® Completes the Acquisition of Resolution Medical, Expanding End-to-End Integrated Capabilities for Interventional and Neuromodulation Markets

    NASHUA, N.H., March 23, 2026 /PRNewswire/ -- Resonetics® announced today the successful completion of its acquisition of Resolution Medical, which further strengthens its ability to deliver integrated, end-to-end device solutions for customers in the interventional, structural heart, and neuromodulation markets. The acquisition expands Resonetics' design, finished device and sub-assembly capabilities, enabling broader support across the full product lifecycle from early concept and development through commercialization and scaled production. By incorporating Resolution Medical's

    3/23/26 8:59:00 AM ET
    $CG
    Investment Managers
    Finance

    $CG
    $CGBD
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by The Carlyle Group Inc.

    SCHEDULE 13G/A - Carlyle Group Inc. (0001527166) (Subject)

    3/26/26 4:44:46 PM ET
    $CG
    Investment Managers
    Finance

    SEC Form 10-K filed by The Carlyle Group Inc.

    10-K - Carlyle Group Inc. (0001527166) (Filer)

    2/27/26 4:13:57 PM ET
    $CG
    Investment Managers
    Finance

    The Carlyle Group Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Carlyle Group Inc. (0001527166) (Filer)

    2/26/26 7:00:39 AM ET
    $CG
    Investment Managers
    Finance

    $CG
    $CGBD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Carlyle Secured Lending upgraded by B. Riley Securities with a new price target

    B. Riley Securities upgraded Carlyle Secured Lending from Neutral to Buy and set a new price target of $13.00

    2/25/26 12:43:37 PM ET
    $CGBD
    Finance: Consumer Services
    Finance

    RBC Capital Mkts initiated coverage on Carlyle Group with a new price target

    RBC Capital Mkts initiated coverage of Carlyle Group with a rating of Outperform and set a new price target of $67.00

    2/24/26 7:47:48 AM ET
    $CG
    Investment Managers
    Finance

    UBS resumed coverage on Carlyle Group with a new price target

    UBS resumed coverage of Carlyle Group with a rating of Buy and set a new price target of $74.00

    12/11/25 9:06:22 AM ET
    $CG
    Investment Managers
    Finance

    $CG
    $CGBD
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO Chi Alex bought $97,127 worth of shares (9,000 units at $10.79) (SEC Form 4)

    4 - Carlyle Secured Lending, Inc. (0001544206) (Issuer)

    3/10/26 4:06:38 PM ET
    $CGBD
    Finance: Consumer Services
    Finance

    CFO and President Hennigan Thomas M bought $49,882 worth of shares (4,430 units at $11.26), increasing direct ownership by 5% to 101,325 units (SEC Form 4)

    4 - Carlyle Secured Lending, Inc. (0001544206) (Issuer)

    3/5/26 4:05:26 PM ET
    $CGBD
    Finance: Consumer Services
    Finance

    CFO Hennigan Thomas M bought $101,136 worth of shares (8,400 units at $12.04), increasing direct ownership by 9% to 96,895 units (SEC Form 4)

    4 - Carlyle Secured Lending, Inc. (0001544206) (Issuer)

    11/17/25 4:10:29 PM ET
    $CGBD
    Finance: Consumer Services
    Finance

    $CG
    $CGBD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Taylor Francis

    4 - Carlyle Secured Lending, Inc. (0001544206) (Issuer)

    3/23/26 4:06:44 PM ET
    $CGBD
    Finance: Consumer Services
    Finance

    SEC Form 4 filed by Rubenstein David M.

    4 - Carlyle Group Inc. (0001527166) (Issuer)

    3/20/26 5:34:13 PM ET
    $CG
    Investment Managers
    Finance

    SEC Form 3 filed by new insider Taylor Francis

    3 - Carlyle Secured Lending, Inc. (0001544206) (Issuer)

    3/18/26 4:30:57 PM ET
    $CGBD
    Finance: Consumer Services
    Finance

    $CG
    $CGBD
    Financials

    Live finance-specific insights

    View All

    Carlyle Presents Growth Outlook at 2026 Shareholder Update

    WASHINGTON and NEW YORK, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Global investment firm Carlyle (NASDAQ:CG) is announcing its growth outlook and financial objectives at the 2026 Shareholder Update, beginning today at 8:30 a.m. EST. The program will include presentations by senior leadership, followed by a Q&A session. Carlyle will announce three-year financial targets to be achieved by the end of 2028, including: FRE of $1.9+ billionInflows of $200+ billionDE per common share of $6.00+ Carlyle is also announcing that its Board of Directors has approved a new $2 billion share repurchase authorization. The authorization provides the firm with flexibility to repurchase shares as part of its disc

    2/26/26 7:01:00 AM ET
    $CG
    Investment Managers
    Finance

    Carlyle Secured Lending, Inc. Announces Financial Results For Fourth Quarter and Full Year Ended December 31, 2025, Declares First Quarter 2026 Dividend of $0.40 Per Common Share

    NEW YORK, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Carlyle Secured Lending, Inc. (together with its consolidated subsidiaries, "we," "us," "our," "CGBD" or the "Company") (NASDAQ:CGBD) today announced its financial results for its fourth quarter and full year ended December 31, 2025. Alex Chi, CGBD's Chief Executive Officer, said, "As CGBD's newly appointed CEO, I look forward to continuing to build on Carlyle's strong track record and world-class platform. Building off record origination volume in the fourth quarter and full year 2025, we continue to expand our origination apparatus and are focused on further harnessing the full power of the OneCarlyle platform. The depth of our underwriting se

    2/24/26 4:05:00 PM ET
    $CG
    $CGBD
    Investment Managers
    Finance
    Finance: Consumer Services

    Carlyle Secured Lending, Inc. Schedules Earnings Release and Quarterly Earnings Call to Discuss its Financial Results for the Fourth Quarter and Full Year Ended December 31, 2025

    NEW YORK, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Carlyle Secured Lending, Inc. ("Carlyle Secured Lending") (NASDAQ:CGBD) will host a conference call at 11:00 a.m. (Eastern Time) on Wednesday, February 25, 2026 to announce its financial results for the fourth quarter and full year ended December 31, 2025. The Company will report its quarterly financial results on Tuesday, February 24, 2026. The conference call will be available via public webcast via a link on Carlyle Secured Lending's website at carlylesecuredlending.com and will also be available on the website soon after the call's completion. About Carlyle Secured Lending, Inc.     Carlyle Secured Lending, Inc. is a publicly traded (NASDA

    1/27/26 4:05:00 PM ET
    $CG
    $CGBD
    Investment Managers
    Finance
    Finance: Consumer Services

    $CG
    $CGBD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by The Carlyle Group Inc.

    SC 13D/A - Carlyle Group Inc. (0001527166) (Subject)

    11/15/24 5:22:29 PM ET
    $CG
    Investment Managers
    Finance

    Amendment: SEC Form SC 13D/A filed by The Carlyle Group Inc.

    SC 13D/A - Carlyle Group Inc. (0001527166) (Filed by)

    10/21/24 4:31:27 PM ET
    $CG
    Investment Managers
    Finance

    Amendment: SEC Form SC 13D/A filed by The Carlyle Group Inc.

    SC 13D/A - Carlyle Group Inc. (0001527166) (Filed by)

    10/15/24 4:31:27 PM ET
    $CG
    Investment Managers
    Finance

    $CG
    $CGBD
    Leadership Updates

    Live Leadership Updates

    View All

    Acentra Health Names New Senior Vice Presidents, Mohamed Karama and Nirav Dalal, to Drive Company Growth and Business Development

    MCLEAN, Va., March 25, 2026 (GLOBE NEWSWIRE) -- Acentra Health, a technology and health solutions and services company dedicated to accelerating better outcomes for its government and commercial healthcare clients and the populations they serve, announced today that Mohamed Karama has joined the company as Senior Vice President of Growth Acceleration and Performance, and Nirav Dalal has been promoted to Senior Vice President of Sales Leadership. These appointments advance Acentra Health's transformation initiatives and position the company for strategic growth. "As we continue transforming Acentra Health, we're investing in our growth engine," said Patty Obermaier, EVP, Chief Growth Offic

    3/25/26 9:33:00 AM ET
    $CG
    Investment Managers
    Finance

    Carlyle to Host 2026 Shareholder Update

    WASHINGTON and NEW YORK, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Global investment firm Carlyle (NASDAQ:CG) announced today that it will host a Shareholder Update on Thursday, February 26, 2026. The Shareholder Update will include a series of presentations by the company's senior leadership team and will review Carlyle's growth outlook and financial objectives. Presentations will begin at 8:30 a.m. EST, followed by a Q&A session. Presentation materials and a live webcast will be posted on the day of the event and can be accessed on the Events & Presentations section of ir.carlyle.com. For those unable to join the live webcast, a replay will be available on the website following the event. Any

    2/2/26 8:01:00 AM ET
    $CG
    Investment Managers
    Finance

    Acentra Health Appoints Balajee Sethuraman as Executive Vice President and Chief Business Services Officer

    MCLEAN, Va., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Acentra Health, a technology and health solutions company dedicated to accelerating better health outcomes for government and commercial clients and the populations they serve, today announced the appointment of Balajee Sethuraman as Executive Vice President and Chief Business Services Officer (CBSO), where he will lead the company's business services and delivery operations. This strategic addition to Acentra Health's executive leadership team supports its ongoing efforts to streamline and strengthen enterprise-wide delivery through a unified operating model. "Balajee is a transformative leader with exceptional experience scaling global team

    1/27/26 9:33:00 AM ET
    $CG
    Investment Managers
    Finance